Education
About Us
Working with TipRanks
Follow Us
MedCap AB (DE:61MA)
:61MA
61MA Stock Chart & Stats
Day’s Range― - ―
52-Week Range€30.85 - €54.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€461.55M
Enterprise Value€8.93B
Total Cash (Recent Filing)kr15.70M
Total Debt (Recent Filing)kr302.70M
Price to Earnings (P/E)26.1
Beta-0.01
Next Earnings
May 02, 2025EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.22
Shares Outstanding14,972,853
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.24
Price to Book (P/B)N/A
Price to Sales (P/S)3.62
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
MedCap AB News
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.18%
Mutual Funds
― Other Institutional Investors
99.58% Public Companies and
Individual Investors
61MA FAQ
What was MedCap AB’s price range in the past 12 months?
MedCap AB lowest stock price was €30.85 and its highest was €54.10 in the past 12 months.
What is MedCap AB’s market cap?
MedCap AB’s market cap is €461.55M.
When is MedCap AB’s upcoming earnings report date?
MedCap AB’s upcoming earnings report date is May 02, 2025 which is in 22 days.
How were MedCap AB’s earnings last quarter?
MedCap AB released its earnings results on Jan 31, 2025. The company reported €0.255 earnings per share for the quarter, beating the consensus estimate of €0.255 by <€0.001.
Is MedCap AB overvalued?
According to Wall Street analysts MedCap AB’s price is currently Overvalued.
Does MedCap AB pay dividends?
MedCap AB does not currently pay dividends.
What is MedCap AB’s EPS estimate?
MedCap AB’s EPS estimate is 0.24.
How many shares outstanding does MedCap AB have?
MedCap AB has 14,972,853 shares outstanding.
What happened to MedCap AB’s price movement after its last earnings report?
MedCap AB reported an EPS of €0.255 in its last earnings report, beating expectations of €0.255. Following the earnings report the stock price went up 3.526%.
Which hedge fund is a major shareholder of MedCap AB?
Currently, no hedge funds are holding shares in DE:61MA
---
Company Description
MedCap AB
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. The company operates in two areas: MedTech and Specialty Pharma.
---
Technical Analysis
Idun Industrier AB Class B
―
Bure Equity AB
―
Vo2 Cap Holding AB
―
Linc AB
―
Svolder AB Class B
―
---